Literature DB >> 17124161

Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.

R Jover, A Castells, X Llor, M Andreu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17124161      PMCID： PMC1856450          DOI： 10.1136/gut.2006.105627

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

Review 1.  Systematic review of microsatellite instability and colorectal cancer prognosis.

Authors:  S Popat; R Hubner; R S Houlston
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

2.  Microsatellite instability and colorectal cancer prognosis.

Authors:  Piero Benatti; Roberta Gafà; Daniela Barana; Massimiliano Marino; Alessandra Scarselli; Monica Pedroni; Iva Maestri; Laura Guerzoni; Luca Roncucci; Mirco Menigatti; Barbara Roncari; Stefania Maffei; Giuseppina Rossi; Giovanni Ponti; Alessandra Santini; Lorena Losi; Carmela Di Gregorio; Cristina Oliani; Maurizio Ponz de Leon; Giovanni Lanza
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

3.  Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.

Authors:  R Jover; P Zapater; A Castells; X Llor; M Andreu; J Cubiella; V Piñol; R M Xicola; L Bujanda; J M Reñé; J Clofent; X Bessa; J D Morillas; D Nicolás-Pérez; A Payá; C Alenda
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

4.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

5.  Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.

Authors:  John M Carethers; E Julieta Smith; Cynthia A Behling; Lanchinh Nguyen; Akihiro Tajima; Ryan T Doctolero; Betty L Cabrera; Ajay Goel; Christian A Arnold; Katsumi Miyai; C Richard Boland
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682
  5 in total
  5 in total

1.  Tumor-based screening for hereditary nonpolyposis colorectal cancer: does age-based selection optimize yield?

Authors:  Patrick M Lynch
Journal:  J Oncol Pract       Date:  2013-04-02       Impact factor: 3.840

2.  Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications.

Authors:  Aziz Zaanan; Katy Meunier; Fatiha Sangar; Jean-François Fléjou; Françoise Praz
Journal:  Cell Oncol (Dordr)       Date:  2011-04-12       Impact factor: 6.730

Review 3.  Colorectal Cancer Biomarkers: Where Are We Now?

Authors:  Maria Gonzalez-Pons; Marcia Cruz-Correa
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

4.  Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients.

Authors:  Francesca Pirini; Luigi Pasini; Gianluca Tedaldi; Emanuela Scarpi; Giorgia Marisi; Chiara Molinari; Daniele Calistri; Alessandro Passardi; Paola Ulivi
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

5.  Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.

Authors:  Ruggero De Maria; Giorgio Stassi; Veronica Veschi; Laura R Mangiapane; Annalisa Nicotra; Simone Di Franco; Emanuela Scavo; Tiziana Apuzzo; Davide S Sardina; Micol Fiori; Antonina Benfante; Maria L Colorito; Gianfranco Cocorullo; Felice Giuliante; Calogero Cipolla; Giuseppe Pistone; Maria Rita Bongiorno; Aroldo Rizzo; Courtney M Tate; Xiaohua Wu; Scott Rowlinson; Louis F Stancato; Matilde Todaro
Journal:  Oncogene       Date:  2019-10-07       Impact factor: 9.867
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.